217 related articles for article (PubMed ID: 16720834)
21. Nucleophosmin (NPM1) mutations in adult and childhood acute myeloid leukaemia: towards definition of a new leukaemia entity.
Rau R; Brown P
Hematol Oncol; 2009 Dec; 27(4):171-81. PubMed ID: 19569254
[TBL] [Abstract][Full Text] [Related]
22. Altered nucleophosmin transport in acute myeloid leukaemia with mutated NPM1: molecular basis and clinical implications.
Falini B; Bolli N; Liso A; Martelli MP; Mannucci R; Pileri S; Nicoletti I
Leukemia; 2009 Oct; 23(10):1731-43. PubMed ID: 19516275
[TBL] [Abstract][Full Text] [Related]
23. A surrogate marker to detect nucleophosnim (NPM1) gene mutations in the cytoplasm of acute myeloid leukemia (AML) blast cells in 30 adult Iraqi patients.
Al-Husseinawi EK
Ann Saudi Med; 2013; 33(6):539-46. PubMed ID: 24413856
[TBL] [Abstract][Full Text] [Related]
24. Monoclonal antibodies against nucleophosmin mutants: potentials for the detection of acute myeloid leukemia.
Tan S; Zhang L; Zhong XM; Yang ZL; Zhao LY; Gao YJ; Shao HY; Qin FX; Chen XC; Zhang HJ; Chen H; Wang L
Int J Med Sci; 2011; 8(4):309-14. PubMed ID: 21611112
[TBL] [Abstract][Full Text] [Related]
25. Prevalence, clinical profile, and prognosis of NPM mutations in AML with normal karyotype.
Boissel N; Renneville A; Biggio V; Philippe N; Thomas X; Cayuela JM; Terre C; Tigaud I; Castaigne S; Raffoux E; De Botton S; Fenaux P; Dombret H; Preudhomme C
Blood; 2005 Nov; 106(10):3618-20. PubMed ID: 16046528
[TBL] [Abstract][Full Text] [Related]
26. Two Novel Mutations of the NPM1 Gene in Syrian Adult Patients with Acute Myeloid Leukemia and Normal Karyotype.
Alarbeed IF; Wafa A; Moassass F; Al-Halabi B; Alachkar W; Aboukhamis I
Asian Pac J Cancer Prev; 2021 Jan; 22(1):227-232. PubMed ID: 33507703
[TBL] [Abstract][Full Text] [Related]
27. Nucleophosmin mutation analysis in acute myeloid leukaemia: Immunohistochemistry as a surrogate for molecular techniques.
Chopra A; Soni S; Pati H; Kumar D; Diwedi R; Verma D; Vishwakama G; Bakhshi S; Kumar S; Gogia A; Kumar R
Indian J Med Res; 2016 Jun; 143(6):763-768. PubMed ID: 27748301
[TBL] [Abstract][Full Text] [Related]
28. XPO1 is a new target of homoharringtonine (HHT): Making NPMc
Xue J; Chu P; Gao W; Wang F; Gao Y; Liu S; Kang Z; Yan J; Wang H
Biochem Biophys Res Commun; 2023 Oct; 675():155-161. PubMed ID: 37473530
[TBL] [Abstract][Full Text] [Related]
29. Identification of NPMc+ acute myeloid leukemia in bone marrow smears.
Bedekovics J; Rejtő L; Telek B; Kiss A; Hevessy Z; Ujfalusi A; Méhes G
Appl Immunohistochem Mol Morphol; 2013 Jan; 21(1):73-8. PubMed ID: 22595947
[TBL] [Abstract][Full Text] [Related]
30. The cytoplasmic NPM mutant induces myeloproliferation in a transgenic mouse model.
Cheng K; Sportoletti P; Ito K; Clohessy JG; Teruya-Feldstein J; Kutok JL; Pandolfi PP
Blood; 2010 Apr; 115(16):3341-5. PubMed ID: 19666870
[TBL] [Abstract][Full Text] [Related]
31. Nucleophosmin in leukemia: Consequences of anchor loss.
Brodská B; Šašinková M; Kuželová K
Int J Biochem Cell Biol; 2019 Jun; 111():52-62. PubMed ID: 31009764
[TBL] [Abstract][Full Text] [Related]
32. Translocations and mutations involving the nucleophosmin (NPM1) gene in lymphomas and leukemias.
Falini B; Nicoletti I; Bolli N; Martelli MP; Liso A; Gorello P; Mandelli F; Mecucci C; Martelli MF
Haematologica; 2007 Apr; 92(4):519-32. PubMed ID: 17488663
[TBL] [Abstract][Full Text] [Related]
33. CXC chemokine receptor 4 expression, CXC chemokine receptor 4 activation, and wild-type nucleophosmin are independently associated with unfavorable prognosis in patients with acute myeloid leukemia.
Konoplev S; Lin P; Yin CC; Lin E; Nogueras González GM; Kantarjian HM; Andreeff M; Medeiros LJ; Konopleva M
Clin Lymphoma Myeloma Leuk; 2013 Dec; 13(6):686-92. PubMed ID: 24035716
[TBL] [Abstract][Full Text] [Related]
34. Role of nucleophosmin in acute myeloid leukemia.
Meani N; Alcalay M
Expert Rev Anticancer Ther; 2009 Sep; 9(9):1283-94. PubMed ID: 19761432
[TBL] [Abstract][Full Text] [Related]
35. Can cytoplasmic nucleophosmin be detected by immunocytochemical staining of cell smears in acute myeloid leukemia?
Mattsson G; Turner SH; Cordell J; Ferguson DJ; Schuh A; Grimwade LF; Bench AJ; Weinberg OK; Marafioti T; George TI; Arber DA; Erber WN; Mason DY
Haematologica; 2010 Apr; 95(4):670-3. PubMed ID: 20015883
[TBL] [Abstract][Full Text] [Related]
36. Nucleophosmin mutations in de novo acute myeloid leukemia: the age-dependent incidences and the stability during disease evolution.
Chou WC; Tang JL; Lin LI; Yao M; Tsay W; Chen CY; Wu SJ; Huang CF; Chiou RJ; Tseng MH; Lin DT; Lin KH; Chen YC; Tien HF
Cancer Res; 2006 Mar; 66(6):3310-6. PubMed ID: 16540685
[TBL] [Abstract][Full Text] [Related]
37. Immunohistochemical Detection of NPM1 Mutation in Acute Myeloid Leukemia and its Association With Cup-like Nuclear Morphology of Blasts.
Rastogi P; Naseem S; Varma N; Varma S
Appl Immunohistochem Mol Morphol; 2016 Apr; 24(4):261-7. PubMed ID: 26200838
[TBL] [Abstract][Full Text] [Related]
38. Nucleophosmin mutations in childhood acute myelogenous leukemia with normal karyotype.
Cazzaniga G; Dell'Oro MG; Mecucci C; Giarin E; Masetti R; Rossi V; Locatelli F; Martelli MF; Basso G; Pession A; Biondi A; Falini B
Blood; 2005 Aug; 106(4):1419-22. PubMed ID: 15870172
[TBL] [Abstract][Full Text] [Related]
39. Quantitative detection of circulating nucleophosmin mutations DNA in the plasma of patients with acute myeloid leukemia.
Quan J; Gao YJ; Yang ZL; Chen H; Xian JR; Zhang SS; Zou Q; Zhang L
Int J Med Sci; 2015; 12(1):17-22. PubMed ID: 25552914
[TBL] [Abstract][Full Text] [Related]
40. [Study of nucleophosmin (NPM) gene mutation in patients with acute myeloid leukemia and myelodysplastic syndromes].
Zhang Y; Zhang MR; Yang L; Xiao ZJ
Zhonghua Xue Ye Xue Za Zhi; 2006 Jul; 27(7):470-3. PubMed ID: 17147251
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
